Pen Insulin Syringe Market is expected to be around US$ 4350 Million by 2028 at a CAGR of 8.0% in the given forecast period.
Technological improvements in insulin infusion devices are one of the developing patterns in the market all-inclusive. Additionally, one of the key factors for the development of the market is the rising number of diabetics because of stoutness, aging, and undesirable ways of life and changing their lifestyle. Obesity is accepted to be a huge factor impacting the development of diabetes in people. The rising power of diabetes in various age bunches alongside creating R&D adventures which are boosting the pen insulin syringe market.
Individuals with diabetes use insulin pens to infuse insulin, an imperative hormone for individuals who have diabetes. They contain a cartridge, a dial to quantify measurement, and an expendable needle. Insulin pens are developing in fame, and numerous individuals with diabetes these days utilize a pen to control insulin. The pens permit progressively straightforward, exact, and advantageous conveyance than utilizing a vial and syringe. Only one out of every odd individual with diabetes should have to take insulin.
The global Pen Insulin Syringe market is segregated on the basis of Product as Disposable Pens and Reusable Pens. Based on Application the global Pen Insulin Syringe market is segmented in Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers, and Hospital Pharmacy.
The global Pen Insulin Syringe market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Pen Insulin Syringe market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Sanofi, Becton, Dickinson, Owen Mumford, Jiangsu Delfu, Wockhardt, Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Biocon, and others are among the major players in the global Pen Insulin Syringe market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Pen Insulin Syringe Market has been segmented as below:
Pen Insulin Syringe Market, By Product
Pen Insulin Syringe Market, By Application
Pen Insulin Syringe Market, By Region
Pen Insulin Syringe Market, By Company
The report covers:
Report Scope:
The global Pen Insulin Syringe market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Pen Insulin Syringe market share. Major industry players with significant revenue share include Sanofi, Becton, Dickinson, Owen Mumford, Jiangsu Delfu, Wockhardt, Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Biocon, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
3D Printed Medical Devices market
Absorbable and Non Absorbable Sutures Market
Active Implantable Medical Devices Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Pen Insulin Syringe Market, By Product
5.1 Introduction
5.2 Disposable Pens
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Reusable Pens
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6. Pen Insulin Syringe Market, By Application
6.1 Introduction
6.2 Retail Pharmacy
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Online Sales
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Diabetes Clinics/ Centers
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Hospital Pharmacy
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Pen Insulin Syringe Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Pen Insulin Syringe, By Product
7.2.2 North America Pen Insulin Syringe, By Application
7.3 Europe
7.3.1 Europe Pen Insulin Syringe, By Product
7.3.2 Europe Pen Insulin Syringe, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Pen Insulin Syringe, By Product
7.4.2 Asia-Pacific Pen Insulin Syringe, By Application
7.5 Rest of the World
7.5.1 Rest of the World Pen Insulin Syringe, By Product
7.5.2 Rest of the World Pen Insulin Syringe, By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Sanofi
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Becton
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Dickinson
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Owen Mumford
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Jiangsu Delfu
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Wockhardt
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Novo Nordisk A/S
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Eli Lilly and Company
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 AstraZeneca plc
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Biocon
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Pen Insulin Syringe Market has been segmented as below:
Pen Insulin Syringe Market, By Product
Pen Insulin Syringe Market, By Application
Pen Insulin Syringe Market, By Region
Pen Insulin Syringe Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
